5V21 image
Deposition Date 2017-03-02
Release Date 2017-03-22
Last Version Date 2023-10-04
Entry Detail
PDB ID:
5V21
Keywords:
Title:
Crystal structure of human SETD2 SET-domain in complex with H3K36M peptide and SAM
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.42 Å
R-Value Free:
0.26
R-Value Work:
0.20
R-Value Observed:
0.20
Space Group:
P 21 21 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Histone-lysine N-methyltransferase SETD2
Gene (Uniprot):SETD2
Chain IDs:A
Chain Length:297
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:Histone H3K36M peptide
Chain IDs:B
Chain Length:15
Number of Molecules:1
Biological Source:Homo sapiens
Primary Citation
Molecular basis for the role of oncogenic histone mutations in modulating H3K36 methylation.
Sci Rep 7 43906 43906 (2017)
PMID: 28256625 DOI: 10.1038/srep43906

Abstact

Histone H3 lysine 36 methylation (H3K36me) is critical for epigenetic regulation and mutations at or near H3K36 are associated with distinct types of cancers. H3K36M dominantly inhibits H3K36me on wild-type histones, whereas H3G34R/V selectively affects H3K36me on the same histone tail. Here we report the crystal structures of SETD2 SET domain in complex with an H3K36M peptide and SAM or SAH. There are large conformational changes in the substrate binding regions of the SET domain, and the K36M residue interacts with the catalytic pocket of SETD2. H3G34 is surrounded by a very narrow tunnel, which excludes larger amino acid side chains. H3P38 is in the trans configuration, and the cis configuration is incompatible with SETD2 binding. Finally, mutations of H3G34 or H3P38 alleviate the inhibitory effects of H3K36M on H3K36me, demonstrating that the stable interaction of H3K36M with SETD2 is critical for its inhibitory effects.

Legend

Protein

Chemical

Disease

Primary Citation of related structures